PDF) Estimating the difference in restricted mean survival times from an individual patient data meta-analysis
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial - The Lancet HIV
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people - ScienceDirect
Vaccines | Free Full-Text | Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers
A mathematical solution to Peto's paradox using Polya's urn model: implications for the aetiology of cancer in general | SpringerLink
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study | PLOS ONE
Take Your Choice by John Frederick Peto - Oil Painting Reproduction
A mathematical solution to Peto's paradox using Polya's urn model: implications for the aetiology of cancer in general | SpringerLink
JCM | Free Full-Text | Practical Model for Residual/Recurrent Cervical Intraepithelial Lesions in Patients with Negative Margins after Cold-Knife Conization
Sensors | Free Full-Text | An Ensemble Learning Model for COVID-19 Detection from Blood Test Samples
Kaplan–Meier survival curves of patients using the LR-TR criteria,... | Download Scientific Diagram
Financial Times 15,978 by PETO – Fifteensquared
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial - The Lancet
Lianna Peto, CIMA - Head of Equity and ESG Research - Hartford Funds | LinkedIn
PDF] Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study | Semantic Scholar
PDF) Anatomical and Functional Effects of Oral Administration of Curcuma Longa and Boswellia Serrata Combination in Patients with Treatment-Naïve Diabetic Macular Edema
A systematic review of taxane-containing regimens for metastatic breast cancer | British Journal of Cancer